Walk to End Alzheimer’s Aims to Raise $1M for Research and Awareness
The Walk to End Alzheimer’s event in Indianapolis is gearing up to raise both funds and awareness for Alzheimer’s disease. With the goal of raising over $1 million for continued research advancement, organizers are hoping to make a significant impact in the fight against this debilitating disease. With more than 6 million Americans already living with Alzheimer’s, it remains a leading cause of death in the United States.
Natalie Sutton, the executive director of the Indianapolis Chapter of the Alzheimer’s Association, stressed the urgency of the cause and the importance of early detection and diagnosis. She highlighted a recent breakthrough in FDA-approved treatment that can slow the progression of Alzheimer’s disease, but emphasized the need to ensure widespread access to this groundbreaking treatment in order to benefit as many people as possible.
The main objective of the upcoming Walk to End Alzheimer’s event is to raise $1.27 million, which will not only contribute to further research but also provide essential care and support services for individuals living with the disease. Additionally, the funds will support the advocacy efforts of the Alzheimer’s Association.
The 2023 Walk, scheduled for Saturday at Michael A. Carroll Stadium at IUPUI, promises a family-friendly atmosphere with various activities for participants. Even four-legged friends will have their own dedicated space called the barking lot, complete with giveaways and water stations. It’s a heartwarming testament to the people and pets joining forces to combat Alzheimer’s.
To register for the Walk to End Alzheimer’s and make a difference in the lives of those affected by the disease, interested individuals can visit the event’s official website.
By actively participating in events like the Walk to End Alzheimer’s, communities come together to raise funds, awareness, and hope for a future free from the burdens of this devastating disease. With ongoing support, research advancements, and increased access to treatment, we can make significant strides towards defeating Alzheimer’s and improving the lives of millions of individuals and their families.
